GLP-1: target for a new class of antidiabetic agents? - Wikidata - wikimedia - TriplyDB

GLP-1: target for a new class of antidiabetic agents?

GLP-1: target for a new class of antidiabetic agents?

http://www.wikidata.org/entity/Q55116155

about

Insulin secretion induced by glucose-dependent insulinotropic polypeptide requires phosphatidylinositol 3-kinase γ in rodent and human β-cells.Nutritional regulation of glucagon-like peptide-1 secretion.The neurotransmitters glycine and GABA stimulate glucagon-like peptide-1 release from the GLUTag cell line.

P2860

Q34509761-EBFDDE5E-E68C-489B-935B-F987EBEC20AB Q37322912-F6AB28C6-5DAC-406C-954C-82859AF54128 Q40362301-72A1A430-7598-4E6B-8EE6-435A37B0A758

P2860

GLP-1: target for a new class of antidiabetic agents?

http://www.wikidata.org/entity/Q55116155

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

GLP-1: target for a new class of antidiabetic agents?

@en

GLP-1: target for a new class of antidiabetic agents?

@nl

type

label

GLP-1: target for a new class of antidiabetic agents?

@en

GLP-1: target for a new class of antidiabetic agents?

@nl

prefLabel

GLP-1: target for a new class of antidiabetic agents?

@en

GLP-1: target for a new class of antidiabetic agents?

@nl

P1433

Q55116155-39C31E6E-FF05-445F-8539-529814518DD2

P1476

Q55116155-82A17C56-D357-4C3B-A64F-1ECBED1C8732

P2093

Q55116155-C67CA723-0333-4BCC-9676-87BEAC8E3E63

P2860

Q55116155-0011C8CB-E10E-48C1-BC1B-B7A7C044A9B1

Q55116155-0430FD96-AFFC-4842-BFE5-DCA50F10F2E6

Q55116155-105A0C0D-AE6E-4874-BF16-13FFB3CE70CD

Q55116155-12FEBC56-A980-4CCD-8B7A-FCAF56854E6C

Q55116155-152920D1-7769-4E60-8B1B-D34182E5D0E9

Q55116155-19C98ADE-6078-4EE9-AF5C-3D5150DA49B0

Q55116155-1C89F785-7265-4731-BFD1-4AAD188E51E7

Q55116155-20678390-F7E0-4F96-810C-8FF541FC0D84

Q55116155-2793FBF2-7700-4DFE-BCE2-189C0C69AB74

Q55116155-2B48A6BC-4068-4EDB-9B04-BD9528B0282A

P304

Q55116155-DFCB9134-6006-4E54-BCC3-F7412F4E9EC8

P31

Q55116155-4B217138-D548-4B71-8594-99F2EB24C3FC

P356

Q55116155-69D8F9A2-CE3C-426E-A145-9D59C0D9BD01

P407

Q55116155-F8D428DE-D093-484A-9A87-940AEC4C9CB7

P433

Q55116155-1749FEC5-785E-4644-893E-2A0B665CEDA7

P478

Q55116155-E9D89498-4261-402D-9A07-AAE087E11554

P577

Q55116155-71FCF243-6811-47F7-9977-B88D910E79AE

P5875

Q55116155-40CBB3E0-E8B2-4455-B9E4-418764B5CFD3

P698

Q55116155-8B94B0C2-E901-40F4-B254-D5AACD98120F

P932

Q55116155-D2BE7A98-F9C6-49A0-856C-4688CBC57136

P356

P1433

Journal of the Royal Society of Medicine

P1476

GLP-1: target for a new class of antidiabetic agents?

@en

P2093

C Mark B Edwards

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration

Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Insulin-promoter-factor 1 is required for pancreas development in mice

Minireview: the glucagon-like peptides.

P304

270-274

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1258/JRSM.97.6.270

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8534117

http://www.w3.org/2001/XMLSchema#string

P698

15173327

http://www.w3.org/2001/XMLSchema#string

P932

1079489

http://www.w3.org/2001/XMLSchema#string